Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Given Average Rat

Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Rating) have received a consensus recommendation of “Moderate Buy” from the twenty-one analysts that are presently covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation, ten have issued a buy recommendation and one has assigned a strong buy recommendation to […]

Related Keywords

San Diego , California , United States , Canada , Williamh Rastetter , Kevinc Gorman , Neurocrine Biosciences , Wyliew Vale , Nasdaq , Royal Bank , Acadian Asset Management , Wells Fargo Company , Neurocrine Biosciences Company Profile , Bessemer Group Inc , Kb Financial Partners , Neurocrine Biosciences Inc , Covestor Ltd , Piershale Financial Group Inc , Get Rating , Biosciences Trading Down , Director William , Asset Management , Financial Group , Neurocrine Biosciences Daily , Nasdaq Nbix , Nbix , Medical , 64125c10 , Ratings , Consensus ,